Cargando…

Ten years of progress in radiation oncology

Over the last decade, BMC Cancer has continuously published important research from the field of radiation oncology. Major developments in this field include the introduction of new imaging modalities into radiotherapy planning, the availability of hardware and software for more precise delivery of...

Descripción completa

Detalles Bibliográficos
Autor principal: Vordermark, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259125/
https://www.ncbi.nlm.nih.gov/pubmed/22128868
http://dx.doi.org/10.1186/1471-2407-11-503
_version_ 1782221349326946304
author Vordermark, Dirk
author_facet Vordermark, Dirk
author_sort Vordermark, Dirk
collection PubMed
description Over the last decade, BMC Cancer has continuously published important research from the field of radiation oncology. Major developments in this field include the introduction of new imaging modalities into radiotherapy planning, the availability of hardware and software for more precise delivery of radiation dose, the individualization of radiotherapy concepts, for example, based on microarray data, and the combination of radiotherapy with molecular targeting approaches to overcome the radioresistance of tumor cells.
format Online
Article
Text
id pubmed-3259125
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32591252012-01-17 Ten years of progress in radiation oncology Vordermark, Dirk BMC Cancer Commentary Over the last decade, BMC Cancer has continuously published important research from the field of radiation oncology. Major developments in this field include the introduction of new imaging modalities into radiotherapy planning, the availability of hardware and software for more precise delivery of radiation dose, the individualization of radiotherapy concepts, for example, based on microarray data, and the combination of radiotherapy with molecular targeting approaches to overcome the radioresistance of tumor cells. BioMed Central 2011-11-30 /pmc/articles/PMC3259125/ /pubmed/22128868 http://dx.doi.org/10.1186/1471-2407-11-503 Text en Copyright ©2011 Vordermark; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Vordermark, Dirk
Ten years of progress in radiation oncology
title Ten years of progress in radiation oncology
title_full Ten years of progress in radiation oncology
title_fullStr Ten years of progress in radiation oncology
title_full_unstemmed Ten years of progress in radiation oncology
title_short Ten years of progress in radiation oncology
title_sort ten years of progress in radiation oncology
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259125/
https://www.ncbi.nlm.nih.gov/pubmed/22128868
http://dx.doi.org/10.1186/1471-2407-11-503
work_keys_str_mv AT vordermarkdirk tenyearsofprogressinradiationoncology